Skip to main content
Live · TradingView
Back to the NewsWire

Clinicaltrialvanguard

Published September 15, 2026

Definium's DT120 ODT Meets Primary Endpoint in Phase 3 GAD Study

Read the full story at Clinicaltrialvanguard

DT120 ODT is a formulated version of lysergide ( LSD ) built on Catalent's Zydis fast-dissolve tablet technology, which Definium selected to improve.

Surfaced by this Google Alert

  • LSD